Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Enteral Feeding Formula Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Enteral Feeding Formula Market Trends and Forecast

The future of the global enteral feeding formula market looks promising with opportunities in the oncology, gastrointestinal disease, neurological disorder, and diabetic applications. The global enteral feeding formula market is expected to reach an estimated $9.2 billion by 2028 with a CAGR of 7.0% from 2023 to 2028 The major drivers for this market are increasing aging population, growing cases of chronic diseases, such as diabetes, cancer, gastrointestinal diseases, and neurological disorders, and rising awareness of the enteral nutrition benefits.   
Enteral Feeding Formula by Product, Stage, Application, and End Use Industry
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below. 
Enteral Feeding Formula by Segments

Enteral Feeding Formula by Segment

The study includes trends and forecast for the global enteral feeding formula market by product, stage, application, end use industry, and region, as follows:

Enteral Feeding Formula by Product [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Standard Formulas
  • Disease Specific
  • Diabetic Formulas
  • Renal Formulas
  • Hepatic Formulas
  • Pulmonary Formulas
  • Other Disease Specific Formulas
  • Peptide Based Formulas
  • Other

Enteral Feeding Formula by Stage [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Adults
  • Pediatric

Enteral Feeding Formula by Application [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Oncology
  • Gastrointestinal Diseases
  • Neurological Disorders
  • Diabetes
  • Other

Enteral Feeding Formula by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Hospitals
  • Long Term Care facilities
  • Nursing Homes
  • Assisted Living Facilities
  • Home Care Agencies & Hospices

Enteral Feeding Formula by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Enteral Feeding Formula Companies

Companies in the market compete on the basis of type quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, enteral feeding formula companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduced production costs, and expand their customer base. Some of the enteral feeding formula companies profiled in this report include- 

Enteral Feeding Formula Market Insights

  • Lucintel forecasts that pediatric are expected to witness the higher growth over the forecast period due increasing preterm birth rate along with rising chronic condition in the pediatric patients.
  • Within this market, gastrointestinal diseases are expected to witness the highest growth over the forecast period due to increasing cases of gastrointestinal diseases and disorders among population.
  • North America is expected to remain the largest region over the forecast period due to rising incidence of chronic diseases in the region and increasing inclination of population towards enteral nutrition.

Features of the Enteral Feeding Formula

  • Market Size Estimates: Enteral feeding formula market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Enteral feeding formula market size by various segments, such as product, stage, application, end use industry, and region
  • Regional Analysis: Enteral feeding formula market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different products, stages, applications, end use industries, and regions for the enteral feeding formula market.
  • Strategic Analysis: This includes M&A, new type development, and competitive landscape for the enteral feeding formula market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the enteral feeding formula market size?
Answer: The global enteral feeding formula market is expected to reach an estimated $9.2 billion by 2028.
Q2. What is the growth forecast for enteral feeding formula market?
Answer: The global enteral feeding formula market is expected to grow with a CAGR of 7.0% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the enteral feeding formula market?
Answer: The major drivers for this market are increasing aging population, growing cases of chronic diseases, such as diabetes, cancer, gastrointestinal diseases, and neurological disorders, and rising awareness of the enteral nutrition benefits.
Q4. What are the major segments for enteral feeding formula market?
Answer: The future of the enteral feeding formula market looks promising with opportunities in the oncology, gastrointestinal disease, neurological disorder, and diabetic applications.
Q5. Who are the key enteral feeding formula companies?
Answer: Some of the key enteral feeding formula companies are as follows:
  • Abbott
  • Nestlé S.A
  • Danone S.A
  • Fresenius Kabi
  • B. Braun Melsungen AG
Q6. Which enteral feeding formula segment will be the largest in future?
Answer: Lucintel forecasts that pediatric are expected to witness the higher growth over the forecast period due increasing preterm birth rate along with rising chronic condition in the pediatric patients.
Q7. In enteral feeding formula market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to remain the largest region over the forecast period due to rising incidence of chronic diseases in the region and increasing inclination of population towards enteral nutrition.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

Q.1. What are some of the most promising, high-growth opportunities for the global enteral feeding formula market by product (standard formula, disease specific, diabetic formulas, renal formulas, hepatic formula, pulmonary formulas, other disease specific formulas, peptide based formulas, and others), stage (adults and pediatric), application (oncology, gastrointestinal diseases, neurological disorders, diabetes, and others), end use industry (hospitals, long term care facilities, nursing homes, assisted living facilities, and home care agencies & hospices), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?
Q.11. What M&A activity did occur in the last five years and how did they impact the industry?

For any questions related to enteral feeding formula market or related to enteral feeding formula companies, enteral feeding formula market size, enteral feeding formula market share, enteral feeding formula analysis, enteral feeding formula market growth, enteral feeding formula market research, write Lucintel analyst at email: helpdesk@lucintel.com we will be glad to get back to you soon.
Table of Contents
 
1. Executive Summary
 
2. Global Enteral Feeding Formula Market: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
 
3. Market Trends and Forecast Analysis from 2017 to 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Enteral Feeding Formula Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Enteral Feeding Formula by Product
3.3.1: Standard Formulas
3.3.2: Disease Specific
3.3.3: Diabetic Formulas
3.3.4: Renal Formulas
3.3.5: Hepatic Formulas
3.3.6: Pulmonary Formulas
3.3.7: Other Disease Specific Formulas
3.3.8: Peptide based Formulas
3.3.9: Other Formulas
3.4: Global Enteral Feeding Formula by Stage
3.4.1: Adults
3.4.2: Pediatric
3.5: Global Enteral Feeding Formula by Application
3.5.1: Oncology
3.5.2: Gastrointestinal Diseases
3.5.3: Neurological Disorders
3.5.4: Diabetes
3.5.5: Other Applications
3.6: Global Enteral Feeding Formula by End Use Industry
3.6.1: Hospitals
3.6.2: Long Term Care facilities
3.6.3: Nursing Homes
3.6.4: Assisted Living Facilities
3.6.5: Home Care Agencies & Hospices
 
4. Market Trends and Forecast Analysis by Region from 2017 to 2028
4.1: Global Enteral Feeding Formula by Region
4.2: North American Enteral Feeding Formula 
4.2.1: North American Enteral Feeding Formula by Stage: Adults and Pediatric
4.2.2: North American Enteral Feeding Formula by Application: Oncology, Gastrointestinal Diseases, Neurological Disorders, Diabetes, and Other Applications
4.3: European Enteral Feeding Formula 
4.3.1: European Enteral Feeding Formula by Stage: Adults and Pediatric
4.4.2: European Enteral Feeding Formula by Application: Oncology, Gastrointestinal Diseases, Neurological Disorders, Diabetes, and Other Applications
4.4: APAC Enteral Feeding Formula
4.4.1: APAC Enteral Feeding Formula by Stage: Adults and Pediatric
4.4.2: APAC Enteral Feeding Formula by Application: Oncology, Gastrointestinal Diseases, Neurological Disorders, Diabetes, and Other Applications
4.5: ROW Enteral Feeding Formula  
4.5.1: ROW Enteral Feeding Formula by Stage: Adults and Pediatric
4.5.2: ROW Enteral Feeding Formula by Application: Oncology, Gastrointestinal Diseases, Neurological Disorders, Diabetes, and Other Applications 
 
5. Competitor Analysis
5.1: Type Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
 
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Enteral Feeding Formula by Product 
6.1.2: Growth Opportunities for the Global Enteral Feeding Formula by Stage 
6.1.3: Growth Opportunities for the Global Enteral Feeding Formula by Application
6.1.4: Growth Opportunities for the Global Enteral Feeding Formula by End Use Industry
6.1.5: Growth Opportunities for the Global Enteral Feeding Formula by Region 
6.2: Emerging Trends in the Global Enteral Feeding Formula  
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Enteral Feeding Formula  
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Enteral Feeding Formula  
6.3.4: Certification and Licensing
 
7. Company Profiles of Leading Players
7.1: Abbott
7.2: Nestlé S.A
7.3: Danone S.A
7.4: Fresenius Kabi
7.5: B. Braun Melsungen AG
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Enteral Feeding Formula Market: Trends, Opportunities and Competitive Analysis [2023-2028] Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Enteral Feeding Formula Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?

Follow us on